Related content

Nephrogenic adenoma of the bladder in renal transplant and non-renal transplant patients: a review of 22 cases

By Tse V.   Khadra M.   Eisinger D.   Mitterdorfer A.   Boulas J.   Rogers J.  

Urology, Vol. 50, Iss. 5, 1997-11 ,pp. : 690-696

Elsevier

Access to resources Recommend Favorite

Immunotherapy for Renal Cell Carcinoma

By Bleumer I.   Oosterwijk E.   De Mulder P.   Mulders P.F.A.  

European Urology, Vol. 44, Iss. 1, 2003-07 ,pp. : 65-75

Elsevier

Access to resources Recommend Favorite

Surgical Treatment of Pancreatic Metastases from Renal Cell Carcinomas

By  

Digestive Surgery, Vol. 15, Iss. 3, 1998-05 ,pp. : 241-246

Karger

Access to resources Recommend Favorite

Dendritic cell-based immunotherapy for metastatic renal cell cancer

By Holtl L.   Zelle-Rieser C.   Gander H.   Papesh C.   Ramoner R.   Bartsch G.   Thurnher M.  

European Urology Supplements, Vol. 1, Iss. 1, 2002-01 ,pp. : 110-110

Elsevier

Access to resources Recommend Favorite

Immunotherapy for renal cell carcinoma: the era of interleukin-2-based treatment

By Taneja S.S.   Pierce W.   Figlin R.   Belldegrun A.  

Urology, Vol. 45, Iss. 6, 1995-06 ,pp. : 911-924

Elsevier

Access to resources Recommend Favorite